Peter Gaede

Summary

Affiliation: University of Copenhagen
Country: Denmark

Publications

  1. ncbi Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate
    Peter Gaede
    Steno Diabetes Center, Gentofte, Copenhagen, Denmark
    Nephrol Dial Transplant 18:539-42. 2003
  2. ncbi PROactive study
    Peter Gaede
    Lancet 367:23-4; author reply 26-7. 2006
  3. ncbi Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients
    P Gaede
    Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark
    Diabet Med 18:756-60. 2001
  4. ncbi Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria
    Peter Gaede
    Steno Diabetes Center, Gentofte, Denmark
    Nephrol Dial Transplant 19:2784-8. 2004
  5. ncbi Effect of a multifactorial intervention on mortality in type 2 diabetes
    Peter Gaede
    Steno Diabetes Center, Copenhagen, Denmark
    N Engl J Med 358:580-91. 2008
  6. ncbi Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes
    Peter Gaede
    Steno Diabetes Center, Niels Steensensvej 2, 2820 Gentofte, Copenhagen, Denmark
    Ann Med 36:355-66. 2004
  7. ncbi Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy
    Peter Rossing
    Steno Diabetes Center, Gentofte, Denmark
    Diabetes Care 29:1024-30. 2006
  8. ncbi Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis
    Peter Gaede
    Steno Diabetes Center, Niels Steensens Vej 2, DK 2820 Gentofte, Copenhagen, Denmark
    Diabetes 53:S39-47. 2004
  9. ncbi Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    Peter Gaede
    Steno Diabetes Center, Copenhagen, Denmark
    N Engl J Med 348:383-93. 2003
  10. ncbi Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study
    Peter Gaede
    Steno Diabetes Center, Copenhagen, Denmark
    Diabetes Care 31:1510-5. 2008

Collaborators

Detail Information

Publications12

  1. ncbi Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion rate
    Peter Gaede
    Steno Diabetes Center, Gentofte, Copenhagen, Denmark
    Nephrol Dial Transplant 18:539-42. 2003
    ..Whether a similar effect on AER exists during low-dose ASA treatment, which may confound the diagnosis and monitoring of micro- and macroalbuminuria in type 2 diabetic patients, remains to be elucidated...
  2. ncbi PROactive study
    Peter Gaede
    Lancet 367:23-4; author reply 26-7. 2006
  3. ncbi Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients
    P Gaede
    Steno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark
    Diabet Med 18:756-60. 2001
    ..We tested the hypothesis that supplementation of both vitamin C and E in pharmacological doses lowers AER in Type 2 diabetic patients with persistent micro/macroalbuminuria...
  4. ncbi Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria
    Peter Gaede
    Steno Diabetes Center, Gentofte, Denmark
    Nephrol Dial Transplant 19:2784-8. 2004
    ..However, the long-term impact of stabilization/regression in albuminuria on decline in glomerular filtration rate (GFR) has not been established...
  5. ncbi Effect of a multifactorial intervention on mortality in type 2 diabetes
    Peter Gaede
    Steno Diabetes Center, Copenhagen, Denmark
    N Engl J Med 358:580-91. 2008
    ..We evaluated whether this approach would have an effect on the rates of death from any cause and from cardiovascular causes...
  6. ncbi Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes
    Peter Gaede
    Steno Diabetes Center, Niels Steensensvej 2, 2820 Gentofte, Copenhagen, Denmark
    Ann Med 36:355-66. 2004
    ....
  7. ncbi Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy
    Peter Rossing
    Steno Diabetes Center, Gentofte, Denmark
    Diabetes Care 29:1024-30. 2006
    ....
  8. ncbi Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis
    Peter Gaede
    Steno Diabetes Center, Niels Steensens Vej 2, DK 2820 Gentofte, Copenhagen, Denmark
    Diabetes 53:S39-47. 2004
    ..The challenge for now is to ensure that the trial experiences are widely adopted in daily clinical practice...
  9. ncbi Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    Peter Gaede
    Steno Diabetes Center, Copenhagen, Denmark
    N Engl J Med 348:383-93. 2003
    ..79). CONCLUSIONS: A target-driven, long-term, intensified intervention aimed at multiple risk factors in patients with type 2 diabetes and microalbuminuria reduces the risk of cardiovascular and microvascular events by about 50 percent...
  10. ncbi Cost-effectiveness of intensified versus conventional multifactorial intervention in type 2 diabetes: results and projections from the Steno-2 study
    Peter Gaede
    Steno Diabetes Center, Copenhagen, Denmark
    Diabetes Care 31:1510-5. 2008
    ..To assess the cost-effectiveness of intensive versus conventional therapy for 8 years as applied in the Steno-2 study in patients with type 2 diabetes and microalbuminuria...
  11. ncbi Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study
    Oluf Pedersen
    Steno Diabetes Center, Copenhagen, Denmark
    Metabolism 52:19-23. 2003
    ..The challenge is to ensure that this experience is widely adopted in daily practice...
  12. ncbi Polymorphisms in the 3' UTR in the neurocalcin delta gene affect mRNA stability, and confer susceptibility to diabetic nephropathy
    Masumi Kamiyama
    Laboratory for Diabetic Nephropathy, SNP Research Centre, Institute of Physical and Chemical Research, 1 7 22 Suehiro cho, Tsurumi ku, Yokohama, Kanagawa 230 0045, Japan
    Hum Genet 122:397-407. 2007
    ..G, P = 0.03, odds ratio = 1.91, 95% CI 1.07-3.42). These results suggest that the NCALD gene is a likely candidate for conferring susceptibility to diabetic nephropathy...